Clinical Trials Browser

Phase 2/3 × Recruiting × Trastuzumab × Clear all

Stomach Neoplasms

NCT07413939 2026-05-11

BREnnA

Phase 2/3 Recruiting

650 enrolled

Breast

HER2-positive Breast Cancer

NCT05786716 2025-12-02

DETERMINE

Phase 2/3 Recruiting

30 enrolled

DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckOther hematologic neoplasmThoracic

Urinary Bladder Neoplasms, Gallbladder Neoplasms, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Skin Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms

NCT05722886 2025-11-24

DETERMINE

Phase 2/3 Recruiting

825 enrolled

LymphoidOther hematologic neoplasm

Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Hematologic Neoplasms

Clinical Trials

To Evaluate IAH0968 in Combination With CAPEOX in HER2-positive Gastric Cancer

BREnnA

DETERMINE

DETERMINE